A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators report in a new pair of studies.
from Latest Science News -- ScienceDaily https://ift.tt/HsW0FdT
No comments:
Post a Comment